The role of polo-like kinase 3 in the response of BRAF-mutant cells to targeted anticancer therapies.

Babagana M, Kichina JV, Slabodkin H, Johnson S, Maslov A, Brown L, Attwood K, Nikiforov MA, Kandel ES
Mol Carcinog. 2020 Jan;59(1):5-14. doi: 10.1002/mc.23123. Epub 2019 Sep 30. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.